Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949403 · ClinicalTrials.gov registry record · Early Phase 1
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
A Early Phase 1 study of Fatty Liver, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
- 2
- Study locations
NCT00949403: Completed Early Phase 1 study of Fatty Liver, sponsored by Washington University School of Medicine.
NCT00949403 is a Early Phase 1 study of Fatty Liver that has completed, run by Washington University School of Medicine. The registered enrollment target is 9 participants, below the 210-participant average among 20 other Fatty Liver trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949403, a Early Phase 1 study of Fatty Liver, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate how the liver receives and uses fats for energy. This will help the investigators further understand the physical and chemical processes responsible for Non-Alcoholic Fatty Liver Disease (NAFLD) in overweight females with or without NAFLD who are scheduled to undergo gastric bypass surgery.
Primary Outcome
Liver fatty acid oxidation as determined by 1-11C-palmitate PET imaging.
Conditions Studied
Interventions
- DRUG Radio pharmaceuticals C-11 Acetate, and C-11 Palmitate
Study Locations (2)
Missouri
- Washington University School of Medicine - St Louis
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-01-19 |
| Phase | Early Phase 1 |
What the finished NCT00949403 record still lists
NCT00949403 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 210-participant average among 20 other Fatty Liver trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Fatty Liver appearing as the primary indexed condition, and to 1 intervention - of which Radio pharmaceuticals C-11 Acetate, and C-11 Palmitate is the first listed.
NCT00949403 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00949403 about?
NCT00949403 is a clinical study titled "Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease". The purpose of this study is to evaluate how the liver receives and uses fats for energy. This will help the investigators further understand the physical and chemical processes responsible for Non-Alcoholic Fatty Liver Disease (NAFLD) in overweight females with or without NAFLD who are scheduled to...
What is the current status of trial NCT00949403?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2010-07. Estimated completion is 2011-01-19.
What conditions does trial NCT00949403 study?
This clinical trial studies the following conditions: Fatty Liver.
What interventions are being tested in trial NCT00949403?
The interventions under investigation include: Radio pharmaceuticals C-11 Acetate, and C-11 Palmitate (DRUG).
Who is sponsoring clinical trial NCT00949403?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00949403 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatty Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00949403's enrollment target sits among peer trials
9 20th of 20 higher than 1 of 20 other Fatty Liver trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatty Liver trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Early Tracking of Childhood Health Determinants (ETCHED) Study
RECRUITING
-
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
RECRUITING
-
Blood Collection Biorepository for Liver Disease Research
RECRUITING
-
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia